Profiling of circulating tumor DNA and tumor tissue for treatment selection in patients with advanced and refractory carcinoma: a prospective, two-stage phase II Individualized Cancer Treatment trial
Jakob M. Riedl(Medical University of Graz), Armin Gerger(Medical University of Graz), Martin Pichler(University of Augsburg), Andrea Berghold(Medical University of Graz), Samantha O. Hasenleithner(Medical University of Graz), Karl Kashofer(Medical University of Graz), Gudrun Pregartner(Medical University of Graz), Thomas Bauernhofer, Florian Posch(Medical University of Graz), Lukas Scheipner(Medical University of Graz), Michael R. Speicher(Medical University of Graz), Stephan Jahn(Medical University of Graz), Ellen Heitzer(Medical University of Graz), Gerald Höefler(Medical University of Graz), Karin Groller(Medical University of Graz), Herbert Stöger(Medical University of Graz)
Cited by 10
Related Papers
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
|Immunity|2013|4.7k
Mutations in <i>GNA11</i> in Uveal Melanoma
|New England Journal of Medicine|2010|1.5k
Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability
|Immunity|2016|1.1k
Cognitive impairment by antibiotic-induced gut dysbiosis: Analysis of gut microbiota-brain communication
|Brain Behavior and Immunity|2016|741
Germline mutations in BAP1 predispose to melanocytic tumors
|Nature Genetics|2011|724